Kang Liping
About Kang Liping
Chief Financial Officer of Longduoduo Company Limited (LDDD) since July 2021; age 41 as listed in the 2025 proxy; holds a bachelor’s degree in Accounting from Inner Mongolia University of Technology (2005) . Previously served as accounting supervisor at Inner Mongolia Guanhong Century Electronic Technology Co., Ltd. (2006–2016) and Inner Mongolia Tiantai Technology Co., Ltd. (2016–2021) . Company performance during her tenure: FY2024 total revenue rose 94% year over year to $7.39M and net income reached $1.36M versus $21K in FY2023 .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Inner Mongolia Guanhong Century Electronic Technology Co., Ltd. | Accounting Supervisor | 2006–2016 | Not disclosed |
| Inner Mongolia Tiantai Technology Co., Ltd. | Accounting Supervisor | 2016–2021 | Not disclosed |
External Roles
- None disclosed in Company filings for public company directorships, committee roles, or other external board service .
Fixed Compensation
- Executive compensation disclosures for FY2024 show that no executive officer had total salary and bonus exceeding $100,000; the Summary Compensation Table provides CEO detail but does not disclose Kang Liping’s specific salary/bonus . No pension, SERP, or deferred compensation plans; no tax gross-ups or perquisites disclosed for executive officers .
Performance Compensation
- No equity compensation plans authorized; no RSUs/PSUs or stock option grants have been made to any executive officer or director since inception .
- No disclosed annual bonus plan with performance metrics (e.g., revenue/EBITDA/TSR); compensation committee retains authority over incentive and equity plans but none have been implemented .
Equity Ownership & Alignment
| Metric | Jan 4, 2024 | Jan 9, 2025 |
|---|---|---|
| Shares beneficially owned | 5,000 | 5,000 |
| Ownership % of outstanding | 0.02% | 0.02% |
| Shares pledged as collateral | Not disclosed | Not disclosed |
| Options (exercisable / unexercisable) | None; no options granted | None; no options granted |
| Unvested RSUs/PSUs | None; no equity plans authorized | None; no equity plans authorized |
| Stock ownership guidelines | Not disclosed | Not disclosed |
Employment Terms
- CFO since July 2021; executive officers have employment contracts providing for payment of disclosed salaries; either party may terminate with 30 days’ prior written notice .
- No severance provisions; no change-in-control arrangements, multiples, or accelerated vesting terms; no clawback policy disclosed in filings (a general Code of Ethics is in place) .
- Non-compete, non-solicit, garden leave, or post-termination consulting terms are not disclosed .
Performance & Track Record
| Metric | FY 2023 | FY 2024 |
|---|---|---|
| Total Revenues ($) | $3,818,560 | $7,389,842 |
| Net Income ($) | $21,085 | $1,363,278 |
- Revenue growth driven primarily by commission revenue from sales agency agreements with Inner Mongolia Honghai Health Management Co., Ltd.; 95%+ revenue concentration represents material business risk .
Board Governance (context)
- Kang Liping is an executive officer (CFO), not a director; independent directors chair Audit, Compensation, and Nominating committees; compensation committee members: Wu Binbin (Chair), Xu Huibo, Ma Jiayang (2025); committee charters exist; no compensation consultants engaged to date .
Say-on-Pay & Shareholder Feedback
| Item (2024 Annual Meeting) | Votes For | Votes Against | Abstain |
|---|---|---|---|
| Advisory approval of executive compensation | 27,686,060 | 0 | 0 |
| Frequency of say-on-pay – 1 year | 0 | — | — |
| Frequency of say-on-pay – 2 years | 0 | — | — |
| Frequency of say-on-pay – 3 years | 27,686,060 | — | — |
| Auditor ratification (FY2024) | 29,934,062 | 0 | 0 |
Compensation Structure Analysis
- Year-over-year mix remains predominantly cash at low levels; no equity programs, options, RSUs, or PSUs in place; no disclosed performance metrics tied to executive pay; no severance/change-in-control economics (reduces pay inflation and golden parachute risk) .
- Strong say-on-pay support and three-year frequency preference from shareholders, implying limited concern over current pay practices at this stage .
Risk Indicators & Red Flags
- Extreme revenue concentration: 95% of FY2024 revenue from a single counterparty (Honghai) with sales agency agreements expiring June 20, 2026; renewal uncertainty poses execution risk .
- Section 16 compliance reported; filings do not disclose hedging or pledging by executives; no evidence of option repricing or equity award modifications (none exist) .
Investment Implications
- Alignment: Kang holds 5,000 shares (0.02%); combined with absence of equity incentives, equity-driven alignment is limited; however, the simple, cash-based comp and lack of severance/change-in-control protections reduce shareholder-unfriendly pay risks .
- Retention and selling pressure: No RSU/option vesting overhang and no equity plan remove typical insider selling catalysts; employment can be terminated on 30 days’ notice, suggesting moderate retention risk without lock-in economics .
- Execution risk: Company’s performance improved materially in FY2024, but the heavy dependence on Honghai through June 2026 introduces significant business and execution risk that can overshadow compensation alignment considerations for the CFO’s role .